Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury

The American Journal of Gastroenterology
R J FontanaDILIN Investigators

Abstract

The long-term outcomes of patients with drug induced liver injury (DILI) are not well described. The aim of this study was to determine the frequency and severity of persistent liver biochemistry abnormalities in DILI patients followed over 2 years. Subjects with evidence of liver injury at 6 months after DILI onset were offered a month 12 and 24 study visit. Amongst the 99 patients with definite, probable, or very likely DILI and available laboratory data at 12 months after DILI onset, 74 (75%) had persistent liver injury (persisters) defined as a serum aspartate aminotransferase (AST) or alanine aminotransferase (ALT) >1.5 × upper limit of normal (ULN) or an alkaline phosphatase >ULN, while 25 (25%) had resolved liver injury (resolvers). On multivariate analysis, month 12 persisters were significantly older (52.6 vs. 43.7 years, P=0.01) and more likely to have a cholestatic lab profile at DILI onset (54 vs. 20%, P<0.01) than resolvers. The month 12 persisters also had significantly poorer SF-36 physical summary scores at DILI onset and throughout follow-up compared with the resolvers (P<0.01). Amongst the 17 subjects with a liver biopsy obtained at a median of 387 days after DILI onset, 9 had chronic cholestasis, 3 had steato...Continue Reading

References

Dec 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D MoradpourM Schmid
Jul 27, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J E WareG L Davis
Jun 28, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M WieseU Oesen
Feb 15, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L B SeeffL Barbosa
Oct 24, 2002·Human Pathology·Romil SaxenaNeil D Theise
Dec 18, 2002·Annals of Internal Medicine·George OstapowiczUNKNOWN U.S. Acute Liver Failure Study Group
Jul 26, 2003·Clinics in Liver Disease·Cynthia Levy, Keith D Lindor
Dec 4, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Pierre BedossaValerie Paradis
Nov 27, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jeffrey D BrowningHelen H Hobbs
Mar 17, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S FengR M Merion
Nov 30, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Raúl J AndradeRamón Hidalgo
Jun 9, 2007·Alimentary Pharmacology & Therapeutics·E BjörnssonR Olsson
Oct 29, 2008·Gastroenterology·Naga ChalasaniUNKNOWN Drug Induced Liver Injury Network (DILIN)
Jan 10, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Robert J FontanaUNKNOWN DILIN Study Group
Jan 22, 2009·Journal of Hepatology·Einar Björnsson, Loa Davidsdottir
Jun 1, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Einar BjörnssonKeith Lindor
Jun 1, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Don C RockeyUNKNOWN US Drug-Induced Liver Injury Network
Feb 18, 2011·Digestive Diseases and Sciences·Albert J Czaja
Oct 11, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Annette S H GouwNeil D Theise
May 12, 2012·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Noriyo YamashikiNorihiro Kokudo
Aug 23, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fahad M KhanNeil D Theise
Oct 20, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Luis FontanaMark J Czaja
Sep 17, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David E KleinerUNKNOWN Drug-Induced Liver Injury Network (DILIN)
Jul 22, 2014·Liver International : Official Journal of the International Association for the Study of the Liver·Robert J FontanaUNKNOWN US Acute Liver Failure Study Group

❮ Previous
Next ❯

Citations

Feb 18, 2016·The American Journal of Gastroenterology·Robert J Fontana
Feb 18, 2016·The American Journal of Gastroenterology·Elizabeth Collyer, Marsha Kay
Mar 24, 2016·Digestive Diseases and Sciences·Andrew S deLemosUNKNOWN Drug-Induced Liver Injury Network (DILIN)
May 5, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Philip SargesJames H Lewis
May 18, 2016·Journal of Hepatology·Inmaculada Medina-CalizUNKNOWN Spanish DILI registry
Feb 6, 2017·Liver International : Official Journal of the International Association for the Study of the Liver·Ayako SuzukiUNKNOWN Drug-induced Liver Injury Network (DILIN)
Dec 14, 2016·Histopathology·David E Kleiner
Nov 10, 2017·Digestive Diseases and Sciences·Jawad AhmadJay H Hoofnagle
May 29, 2018·Journal of Digestive Diseases·Aida Ortega-Alonso, Raúl J Andrade
Jun 12, 2018·Expert Opinion on Drug Metabolism & Toxicology·Petar D PetrovRamiro Jover
Jan 23, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Rachel J ChurchPaul B Watkins
Jul 14, 2018·Liver International : Official Journal of the International Association for the Study of the Liver·Ammar Hassan, Robert J Fontana
Nov 1, 2018·Journal of Digestive Diseases·Rachel J Church, Paul B Watkins
Mar 14, 2019·Current Opinion in Gastroenterology·Hans L TillmannDon C Rockey
Aug 24, 2019·Nature Reviews. Disease Primers·Raul J AndradeGuruprasad P Aithal
Oct 4, 2019·Liver International : Official Journal of the International Association for the Study of the Liver·Raúl J Andrade, Mercedes Robles-Díaz
Oct 3, 2019·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Jiangcheng RongLanjuan Li
Aug 28, 2020·Archives of Toxicology·Miren Garcia-CortesRaúl J Andrade
Jun 27, 2020·Frontline Gastroenterology·Nelia HernandezFernando Bessone
Jan 23, 2019·Current Hepatology Reports·Paul H Hayashi, Einar S Bjornsson
Jul 14, 2019·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Qiu-Ju TianJi-Dong Jia
May 26, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Paul H HayashiUNKNOWN Drug-Induced Liver Injury Network (DILIN) Investigators
Sep 3, 2017·Liver International : Official Journal of the International Association for the Study of the Liver·David E Kleiner
May 15, 2020·Journal of Pediatric Gastroenterology and Nutrition·Vanessa CardenasFrank DiPaola
Feb 7, 2018·Hepatology Communications·Vinay Sundaram, Einar S Björnsson
Nov 13, 2020·Clinical Pharmacology and Therapeutics·Rianne A WeersinkRaúl J Andrade
Jan 7, 2018·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Lara DakhoulUNKNOWN United States Drug Induced Liver Injury Network
Mar 26, 2021·Frontiers in Pharmacology·Qiaoling WangZhengsheng Zou
Aug 21, 2020·The Lancet. Gastroenterology & Hepatology·M Isabel LucenaRaúl J Andrade
Apr 14, 2021·Current Gastroenterology Reports·Brian T LeePriya Grewal
Apr 16, 2021·Frontiers in Medicine·Shuai-Shuai ChenJia-Bo Wang
Apr 20, 2019·Journal of Proteome Research·Zhongyang XieLanjuan Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.